School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
Int J Pharm. 2023 Apr 5;636:122818. doi: 10.1016/j.ijpharm.2023.122818. Epub 2023 Mar 11.
A new technological passage has emerged in the pharmaceutical field, concerning the management, application, and transfer of knowledge from humans to machines, as well as the implementation of advanced manufacturing and product optimisation processes. Machine Learning (ML) methods have been introduced to Additive Manufacturing (AM) and Microfluidics (MFs) to predict and generate learning patterns for precise fabrication of tailor-made pharmaceutical treatments. Moreover, regarding the diversity and complexity of personalised medicine, ML has been part of quality by design strategy, targeting towards the development of safe and effective drug delivery systems. The utilisation of different and novel ML techniques along with Internet of Things sensors in AM and MFs, have shown promising aspects regarding the development of well-defined automated procedures towards the production of sustainable and quality-based therapeutic systems. Thus, the effective data utilisation, prospects on a flexible and broader production of "on demand" treatments. In this study, a thorough overview has been achieved, concerning scientific achievements of the past decade, which aims to trigger the research interest on incorporating different types of ML in AM and MFs, as essential techniques for the enhancement of quality standards of customised medicinal applications, as well as the reduction of variability potency, throughout a pharmaceutical process.
制药领域出现了一条新的技术通道,涉及到知识在人与机器之间的管理、应用和转移,以及先进制造和产品优化流程的实施。机器学习 (ML) 方法已被引入到增材制造 (AM) 和微流控 (MFs) 中,以预测和生成针对定制药物治疗的精确制造的学习模式。此外,鉴于个性化医疗的多样性和复杂性,机器学习已成为质量源于设计策略的一部分,旨在开发安全有效的药物输送系统。在 AM 和 MFs 中使用不同的新型机器学习技术以及物联网传感器,已经在开发可持续和基于质量的治疗系统的明确自动化程序方面显示出了有前景的方面。因此,有效地利用数据,灵活地扩大“按需”治疗的生产。在这项研究中,我们全面回顾了过去十年的科学成就,旨在激发人们对将不同类型的机器学习纳入增材制造和微流控的研究兴趣,将其作为提高定制药物应用质量标准的关键技术,以及减少整个制药过程中的变异性和效力。